Observational studyBMC neurology2026
Fatal inflammation: understanding meningitis mortality in the United States (1999-2020).
Observational study in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMeningitis, an inflammatory condition that affects the meninges, has reported an increase in cases between 2006 and 2016. While in well-resourced settings, the incidence of acute bacterial meningitis has declined to below 0.5-1.5 cases per 100,000 population. Overall, late excess mortality following meningitis is highest within the first two years after discharge, particularly affecting patients aged 30-60 years. This research seeks to analyse these trends and investigate potential disparities in mortality rates based on demographic variables between 1999 and 2020. By quantifying high-risk populations and regional differences, the findings provide evidence to guide targeted public health interventions and resource allocation.
methodsThis retrospective observational study used CDC WONDER data (1999-2020) to analyse mortality trends for individuals aged 1-85 + years. Deaths related to meningitis were identified using ICD-10 codes A17.0, A32.1, A39.0, A87.0, A87.1, A87.2, A87.8, A87.9, B00.3, B01.0, B02.1, B05.1, B26.1, B37.5, B38.4, G00.0, G00.1, G00.2, G00.3, G00.8, G00.9, G03.0, G03.1, G03.2, G03.8, G03.9. Crude mortality rates and age-adjusted mortality rates (AAMRs) were calculated. Temporal trends and significant changes in mortality trajectories were assessed using Joinpoint regression analysis, which estimated annual percentage changes (APCs) and identified statistically significant inflection points. Mortality patterns were further stratified by sex, race or ethnicity, census region, state, and urban-rural classification.
resultsBetween 1999 and 2020, meningitis-related AAMRs in the United States declined from 8.43 to 3.88 per 1,000,000 population, with the steepest decrease between 1999 and 2012 before stabilising thereafter. Males consistently showed higher mortality (AAMR 5.79) compared to females (AAMR 4.53), though both declined substantially over the study period. Non-Hispanic (NH) Black individuals exhibited the highest AAMRs (8.59), followed by Hispanics (4.81), NH Whites (4.64), and NH Asians or Pacific Islanders (3.58). Geographically, the West (5.35) and South (5.33) had the greatest burden, while the Northeast (4.69) and Midwest (4.81) reported lower rates. State-level variation ranged from 8.85 per 1,000,000 in the District of Columbia to 3.52 per 1,000,000 in Delaware, with higher mortality in non-metropolitan areas than metropolitan ones.
conclusionThis study provides a comprehensive analysis of meningitis-related mortality trends in the United States from 1999 to 2020, highlighting significant declines in AAMRs across demographic groups, regions, and urbanisation levels. Despite the overall decline, the stabilisation of AAMRs in the last decade suggests a plateau in progress, necessitating further investigation into the underlying factors. Thus, targeted interventions to enhance the prevention, control, and management of risk factors might be required to achieve lasting change.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.